Background {#s1}
==========

Lower extremity peripheral artery disease (PAD) is highly prevalent, affecting about eight million people aged ≥40 years in the US population.[@R1] [@R2] Although common and associated with significant mortality and morbidity, PAD is a relatively understudied phenotype of atherosclerotic vascular disease. Ascertainment of cases of PAD based on the ankle-brachial index (ABI) may be biased owing to exclusion of patients diagnosed by other procedures, or those who could not tolerate lower extremity arterial evaluation. A reliable method for identifying patients with PAD from hospital-wide databases would be useful for genetic and epidemiologic studies of PAD.

Healthcare encounters are recorded for administrative and reimbursement purposes in the USA.[@R3] Administrative data are readily available, often for large populations, are inexpensive to acquire, and are computer readable. Given these advantages, such data are increasingly being used in medical research. Moreover, the growing use of the electronic medical records (EMRs) and the development and validation of informatics approaches to access diverse phenotypes from the EMR[@R4] may facilitate rapid phenotyping. The accuracy of billing codes for ascertaining disease conditions varies.[@R5; @R6; @R7; @R8; @R9; @R10] For example, the positive predictive value (PPV) of billing codes for acute myocardial infarction was reported to be 96.9%,[@R6] whereas the PPV for pelvic inflammatory disease was only 18.1%.[@R7]

Whether billing codes are useful in ascertaining cases of PAD is unknown. We investigated whether billing codes, which include International Classification of Diseases, 9th revision, clinical modification (ICD-9-CM), and Current Procedural Terminology, 4th revision (CPT-4) codes, could be used for reliable ascertainment of PAD cases from administrative databases. We developed and validated billing algorithms to ascertain PAD status at Mayo Clinic Rochester, Minnesota, using administrative data over an 11-year period.

Methods {#s2}
=======

Study design and population {#s2a}
---------------------------

This historical cohort study was approved by the institutional review board of the Mayo Clinic. We used the Mayo Decision Support System database, which contains administrative billing information on every patient for each encounter (hospital inpatient, hospital outpatient, emergency department, office visit, and nursing home visit) and patient demographics (eg, age, sex, and geographic region). We excluded individuals who refused authorization for use of their medical records for research (n=1650).

Non-invasive lower extremity arterial evaluation {#s2b}
------------------------------------------------

Lower extremity arterial evaluation was performed using standardized protocols in the non-invasive vascular laboratory, which is certified by the Intersocietal Commission for the Accreditation of Vascular Laboratories. Systolic blood pressure was measured in each arm and in the dorsalis pedis and posterior tibial arteries bilaterally using a hand-held 8.3 MHz Doppler probe. The higher of the two arm pressures and the lower of the two ankle pressures were used to calculate the ABI in each leg.[@R11] The data were interpreted and reported by a vascular medicine specialist. Results of all non-invasive lower extremity arterial evaluations are entered into a database that becomes part of the Mayo EMR.

Definition of PAD and normal ABI {#s2c}
--------------------------------

PAD was defined as atherosclerotic occlusive arterial disease of the lower extremities, including arteries distal to the aortic bifurcation. The vascular laboratory diagnostic criteria for PAD were: (1) a resting/post-exercise ABI ≤0.9; or (2) the presence of poorly compressible arteries (ABI \>1.4; or ankle blood pressure \>255 mm Hg).[@R11] Patients with normal non-invasive vascular test(s) were classified as normal ABI.

PAD-related diagnostic and procedural billing codes {#s2d}
---------------------------------------------------

We identified all patients with any encounter at Mayo Clinic (Rochester, Minnesota, USA) between July 1, 1997 and June 30, 2008. We extracted all encounters and line item details including PAD-related billing codes (ICD-9-CM/CPT codes listed in online supplementary tables S1 and S2). Codes were assigned at discharge from each encounter. The encounter-level data contained a maximum of 16 diagnosis codes and a maximum of 16 procedural codes. We used the diagnosis codes assigned in any position of the claim (as primary or secondary diagnosis). We applied ICD-9-CM codes[@R12] created by the US National Center for Health Statistics. In addition, the line item detail data contained all CPT-4 codes[@R13] published and maintained by the American Medical Association, for procedures of line item detail provided during that encounter.

A list of PAD-related ICD-9-CM diagnosis/procedure and CPT-4 procedural codes was compiled through literature review[@R14; @R15; @R16; @R17; @R18; @R19] and manual searches of the ICD-9-CM/CPT code books.[@R12] [@R13] All ICD-9-CM diagnosis codes relevant to lower extremity atherosclerotic disease (eg, 440.2×---atherosclerosis of native arteries of the extremities; 440.3×---atherosclerosis of bypass graft of the extremities; 440.8×---atherosclerosis of other specified arteries; 440.9×---generalized and unspecified atherosclerosis, including arteriosclerotic vascular disease not otherwise specified; 443.9×---peripheral vascular disease, unspecified), CPT-4 or ICD-9-CM procedural codes related to PAD (eg, non-invasive lower extremity arterial evaluation, arteriography, duplex ultrasonography, magnetic resonance angiography, and CT angiography of the lower extremity arteries), or surgical/revascularization procedures related to PAD (eg, lower extremity vascular bypass, percutaneous revascularization, amputation, etc) were included (see online supplementary table S1).

Exclusion codes {#s2e}
---------------

To exclude non-atherosclerotic causes of vascular disease (eg, vasculitis, Buerger\'s disease, etc) and procedures/surgeries (eg, amputation) not related to PAD, we also generated a list of exclusion codes (see online supplementary table S2). These codes were evaluated and finalized by the authors who had expertise in PAD, epidemiology, and informatics. A detailed description of all the billing and procedure codes used in this study is summarized in online supplementary table S3.

Statistical analysis {#s2f}
--------------------

Patients evaluated in the non-invasive vascular laboratory were randomized in a 1:1 manner to create training and validation datasets. Using the training dataset, we performed multiple backward selection logistic regression analyses to estimate the joint association between each patient\'s PAD status and their billing codes using vascular laboratory criteria as the 'gold standard'. Dichotomous variables (ie, presence/absence of the specific code) were created for each billing code. For patients whose PAD status was negative, only billing codes until the last vascular laboratory examination were used as model inputs. For patients whose ultimate PAD status was positive, only billing codes after the first vascular laboratory examination that met PAD criteria were used as model inputs. This was done to ensure that the billing codes reflected the current PAD status of the patient.

In the final logistic regression model 13 billing codes independently predicted PAD status at a significance level of p\<0.001. All had positive β coefficients. For each of these billing codes we assigned a weighted integer coefficient value. To generate the integer score, the β coefficient of each variable which independently predicted PAD status was rounded to the nearest multiple of 0.25.[@R20] To generate the integer we then assigned 1 point for each 0.25 unit increment in the β coefficient. The individual billing code score for each patient was calculated as the sum of these integers. The choice of 0.25, while somewhat arbitrary, was chosen to differentiate relative contributions of codes from each other.

The overall discriminative ability of the final multiple logistic regression model was assessed with the c statistic (the area under the receiver operating characteristic (ROC) curve)[@R21] [@R22] in training and validation datasets, respectively. Using ROC curve analysis, the optimal cut-off point of the billing code score was 8, as determined by a balance of sensitivity and specificity, yielding a sensitivity of 86% and a specificity of 83%. Sensitivity, specificity, PPV, and negative predictive value (NPV) were computed for the billing code score with a selection of possible cut-off points. Sensitivity---true positives/(true positives+ false negatives)---is the proportion of patients with true PAD (determined by the gold standard) classified correctly by the model, and specificity---true negatives/(true negatives+false positives)---is the proportion of patients without PAD (based on vascular laboratory criteria) classified correctly by the model. The proportion of positive calls who truly have PAD, is termed PPV=true positives/(true positives+false positives) and, correspondingly, the proportion of negative calls that are truly negative, is termed NPV=true negatives/(true negatives+false negatives). All the data were analyzed using the SAS 9.13 statistical package (SAS Institute, Cary, North Carolina, USA).

Results {#s3}
=======

Study cohort characteristics {#s3a}
----------------------------

We identified all patients with any encounter at Mayo Clinic (Rochester, Minnesota, USA) between July 1, 1997 and June 30, 2008 (1 221 075 unique patients with 14 531 283 unique encounters) ([figure 1](#AMIAJNL2013001827F1){ref-type="fig"}). A total of 61 005 patients with potential PAD had at least one PAD-related diagnostic/procedural billing code. After exclusion of patients with codes indicating non-atherosclerotic vascular disease (n=4363), a total of 22 723 individuals were evaluated at the Mayo\'s non-invasive vascular laboratory and 33 919 were not. Among the patients evaluated in the vascular laboratory, 11 had inconclusive ABI results and were excluded from subsequent analysis. The remaining set of 22 712 patients was divided into training and validation sets of 11 356 patients each with 7617 (67.1%) and 7573 (66.7%) who met vascular laboratory criteria for PAD, respectively. The demographic characteristics of patients in these two subsets were similar ([table 1](#AMIAJNL2013001827TB1){ref-type="table"}).

###### 

Comparison of patients in the training and validation sets\*

  Variable              Training        Validation      p Value
  --------------------- --------------- --------------- ---------
  Age (years)           68.0±12.5       68.1±12.6       0.53
  Sex (male), n (%)     6681 (58.8)     6582 (58.0)     0.18
  Race (white), n (%)   11 040 (97.2)   11 068 (97.5)   0.25

\*n=11 356 for each dataset.

![Flow diagram of patients in our study. ABI, ankle-brachial index; DSS, Decision Support System; PAD, peripheral arterial disease.](amiajnl-2013-001827f01){#AMIAJNL2013001827F1}

Billing code score development and validation {#s3b}
---------------------------------------------

Thirteen billing codes in the final logistic regression model independently predicted PAD status at p\<0.001 ([table 2](#AMIAJNL2013001827TB2){ref-type="table"}). The billing codes with the largest ORs were: 440.24---atherosclerosis obliterans (ASO) extremities with gangrene (OR=45.4, 95% CI 16.5 to 125.0, p\<0.0001); 440.21---ASO extremities with intermittent claudication (OR=29.9, 95% CI 24.8 to 36.0, p\<0.0001); 440.23---ASO extremities with ulceration (OR=14.6, 95% CI 11.4 to 18.7, p\<0.0001); 440.20---ASO extremities unspecified (OR=11.3, 95% CI 9.3 to 13.9, p\<0.0001); 440.22---ASO extremities with rest pain (OR=9.4, 95% CI 5.9 to 14.8, p\<0.0001); and 84.11---amputation of toe (OR=9.1, 95% CI 3.9 to 21.2, p\<0.0001). The code 440.29---'Atherosclerosis of other native arteries of the extremities' did not reach statistical significance level (p\<0.001), because only a small number of patients (74) in the entire dataset had this code (440.29). The model performed equally well in the training and validation sets with a c statistic of 0.91 for each. The ROC curve analysis showed that assignment of integer scores maintained their good performance in both datasets with c statistics of 0.91 ([figure 2](#AMIAJNL2013001827F2){ref-type="fig"}).

###### 

Thirteen billing codes selected by backward multivariate logistic regression analysis for ascertaining PAD status in the training dataset

  Codes                                  Code description                                               Integer\*   β±SE        OR     95% CI          p Value
  -------------------------------------- -------------------------------------------------------------- ----------- ----------- ------ --------------- ----------
  Diagnosis codes (ICD-9-CM)                                                                                                                           
   440.24                                ASO extremities with gangrene                                  15          3.82±0.52   45.4   16.5 to 125.0   \<0.0001
   440.21                                ASO extremities with intermittent claudication                 14          3.40±0.10   29.9   24.8 to 36.0    \<0.0001
   440.23                                ASO extremities with ulceration                                11          2.68±0.13   14.6   11.4 to 18.7    \<0.0001
   440.20                                ASO extremities, unspecified                                   10          2.43±0.10   11.3   9.3 to 13.9     \<0.0001
   440.22                                ASO extremities with rest pain                                 9           2.24±0.23   9.4    5.9 to 14.8     \<0.0001
   443.9                                 Peripheral vascular disease, unspecified                       7           1.83±0.08   6.2    5.4 to 7.2      \<0.0001
   440.9                                 Generalized and unspecified ASO                                6           1.62±0.10   5.1    4.2 to 6.1      \<0.0001
  Procedural codes (CPT-4 or ICD-9-CM)                                                                                                                 
   84.11                                 Amputation of toe                                              9           2.21±0.43   9.1    3.9 to 21.2     \<0.0001
   75716                                 Angiography, extremity, bilateral, radiological                8           1.91±0.32   6.7    3.6 to 12.5     \<0.0001
   73725                                 MRA lower extremity with or without contrast                   7           1.78±0.44   6.0    2.5 to 14.2     \<0.0001
   75710                                 Angiography, extremity, unilateral, radiological               7           1.87±0.31   6.5    3.5 to 11.9     \<0.0001
   75635                                 CT angiogram---abdominal aorta and lower extremity runoff      6           1.58±0.29   4.8    2.8 to 8.5      \<0.0001
   93922                                 Non-invasive physiologic studies of lower extremity arteries   2           0.59±0.07   1.8    1.6 to 2.0      \<0.0001

\*1 point for each 0.25 unit increment in the β coefficient rounded to the nearest multiple of 0.25.

β, coefficient; ASO, atherosclerosis obliterans; ICD-9-CM, International Classification of Diseases, 9th revision, clinical modification; CPT-4, Current Procedural Terminology, 4th revision; MRA, magnetic resonance angiography; PAD, peripheral artery disease.

![Receiver operating characteristic curve depicting the discriminatory performance of various integer scores. AUC, area under the curve.](amiajnl-2013-001827f02){#AMIAJNL2013001827F2}

Estimates of sensitivity, specificity, PPV, and NPV using different cut-off points of billing code score are summarized in [table 3](#AMIAJNL2013001827TB3){ref-type="table"}. A billing code score ≥8 yielded the best sensitivity and specificity (86% and 83%, respectively) for ascertaining PAD status in the training set with nearly identical performance in the validation set (86% and 82%, respectively). The PPV of billing code score ≥8 was as high as 91% and the NPV was 74% in training set. Predictive values of the billing code score in the validation set were similar to those in the training set.

###### 

Accuracy for classification of PAD status using different cut-off points of billing code score in the training and validation sets\*

  Cut-off point       Sensitivity   Specificity   PPV   NPV                  
  ------------------- ------------- ------------- ----- ----- ---- ---- ---- ----
  Billing score ≥3    91            91            76    75    88   88   80   80
  Billing score ≥5    91            91            76    75    88   88   80   80
  Billing score ≥8    86            86            83    82    91   91   74   74
  Billing score ≥12   79            78            90    89    94   94   68   67

\*n=11 356 for each dataset.

PAD, peripheral artery disease; PPV, positive predictive value; NPV, negative predictive value.

Application of algorithms: patients evaluated in the vascular laboratory {#s3c}
------------------------------------------------------------------------

We applied the model-based billing code algorithm to patients evaluated in the vascular laboratory and compared it with a simpler algorithm---that is, presence of one of the ICD-9 PAD billing codes 440.20-- 440.29. Although the application of the model-based billing code algorithm provided a better NPV, the simpler algorithm was also reasonably accurate for identification of PAD in patients referred to the vascular laboratory, with lesser sensitivity and greater specificity ([table 4](#AMIAJNL2013001827TB4){ref-type="table"}). However, among patients who were negative by the simpler algorithm (10 236), there were 3511 (34.3%) who were truly positive for PAD ([table 5](#AMIAJNL2013001827TB5){ref-type="table"}). The model-based algorithm picked up 1314 of these missed cases, at a cost of 502 additional false positives, and provided highly significant incremental information (p\<0.0001) within this group of patients. Since virtually all the patients who were positive by the simpler algorithm were also positive by the model-based algorithm, there was no additional information provided by the model-based algorithm in this subset.

###### 

Comparison of model-based billing code algorithm versus simpler algorithm: patients evaluated in the vascular laboratory

  Gold standard=ABI                               
  ------------------------- --------------------- ---------------------
  Sensitivity, % (95% CI)   85.5 (85.0 to 86.1)   76.9 (76.2 to 77.6)
  Specificity, % (95% CI)   82.6 (81.7 to 83.5)   89.3 (88.6 to 90.0)
  PPV, % (95% CI)           90.8 (90.4 to 91.3)   93.5 (93.1 to 94.0)
  NPV, % (95% CI)           73.9 (72.9 to 74.8)   65.7 (64.8 to 66.6)

CI calculated by binomial exact distribution.

ABI, ankle-brachial index; NPV, negative predictive value; PPV, positive predictive value.

###### 

Comparison of model-based algorithm versus simpler algorithm in A) patients who underwent testing in the vascular laboratory; and B) patients from the community

  ---------------------------------------------- ------------------------------------- -----------------------------------
  **A. Simpler algorithm negative (n=10 236)**                                         

  **Model-based algorithm negative**\            **Model-based algorithm positive**\   
  **n=8420 (82.3%)**                             **n=1816 (17.7%)**                    

  6223 (73.9%)                                   502 (27.6%)                           **Vascular laboratory negative**\
                                                                                       **n=6725 (65.7%)**

  2197 (26.1%)                                   1314 (72.4%)                          **Vascular laboratory positive**\
                                                                                       **n=3511 (34.3%)**

  **Simpler algorithm positive (n=12 487)**                                            

  **Model-based algorithm negative**\            **Model-based algorithm positive**\   
  **n=3 (0.02%)**                                **n=12 484 (99.98%)**                 

  0 (0.0%)                                       808 (6.5%)                            **Vascular laboratory negative**\
                                                                                       **n=808 (6.5%)**

  3 (100.0%)                                     11 676 (93.5%)                        **Vascular laboratory positive**\
                                                                                       **n=11 679 (93.5%)**

  **B. Simpler algorithm negative (n=172)**                                            

  **Model-based algorithm negative**\            **Model-based algorithm positive**\   
  **n=144 (83.7%)**                              **n=28 (16.3%)**                      

  120 (83.3%)                                    6 (21.4%)                             **Manual abstraction negative**\
                                                                                       **n=126 (73.3%)**

  24 (16.7%)                                     22 (78.6%)                            **Manual abstraction positive**\
                                                                                       **n=46 (26.7%)**

  **Simpler algorithm positive (n=40)**                                                

  **Model-based algorithm negative**\            **Model-based algorithm positive**\   
  **n=0 (0.0%)**                                 **n=40 (100.0%)**                     

  0 (0.0%)                                       11 (27.5%)                            **Manual abstraction negative**\
                                                                                       **n=11 (27.5%)**

  0 (0.0%)                                       29 (72.5%)                            **Manual abstraction positive**\
                                                                                       **n=29 (72.5%)**
  ---------------------------------------------- ------------------------------------- -----------------------------------

Percentages provided in each cell represent column percentages.

PAD, peripheral arterial disease.

Application of algorithms to a community-based sample {#s3d}
-----------------------------------------------------

We used the resources of the Rochester Epidemiology Project (REP)[@R23] to identify a community-based sample of 4420 Olmsted County residents who were not referred to the Mayo vascular laboratory, but who were evaluated at the Mayo Clinic between (July 1, 1997 to July 31, 2008) ([figure 1](#AMIAJNL2013001827F1){ref-type="fig"}) and who had at least one of the PAD-related billing codes described in online supplementary table S1. We divided this sample into three groups: no PAD codes from the model-based algorithm (score=0) (n=2351); score between 1 and 7 (n=1458); score of eight or higher (n=611). Subsequently we randomly selected 75 subjects from each group (random sample n=225) for blinded manual abstraction which was conducted by a single experienced cardiologist (AMA-O). Of these, 13 had unknown PAD status after manual abstraction and were excluded from subsequent analysis. We applied the model-based algorithm to this community-based sample and demonstrated reasonable accuracy of the model-based billing code algorithm for identification of PAD within the sample ([table 6](#AMIAJNL2013001827TB6){ref-type="table"}).

###### 

Comparison of model-based algorithm versus simpler algorithm: community-based sample not evaluated in the vascular laboratory

  Gold standard=Manual chart abstraction                         
  ---------------------------------------- --------------------- ---------------------
  Sensitivity, % (95% CI)                  68.0 (56.2 to 78.3)   38.7 (27.6 to 50.6)
  Specificity, % (95% CI)                  87.6 (80.9 to 92.6)   92.0 (86.1 to 95.9)
  PPV, % (95% CI)                          75.0 (63.0 to 84.7)   72.5 (56.1 to 85.4)
  NPV, % (95% CI)                          83.3 (76.2 to 89.0)   73.3 (66.0 to 79.7)

CI calculated by binomial exact distribution.

NPV, negative predictive value; PPV, positive predictive value.

When we applied the simpler algorithm to this same community-based sample, the sensitivity of the simpler algorithm was lower, and the specificity higher, than that of the model-based algorithm. Both these differences were statistically significant at p\<0.01. Furthermore, as shown in [table 5](#AMIAJNL2013001827TB5){ref-type="table"}, the model-based algorithm was helpful in discriminating PAD status among the 172 subjects found to be negative by the simpler algorithm. Of these, 46 (27%) were truly positive based on manual abstraction. The model-based algorithm captured 22 of these 46 missed cases at a cost of only six false positives, and provided significant incremental information (p\<0.0001) within this group of subjects. In this community-based sample, as in the vascular laboratory population, the model-based algorithm provided no additional information when the simpler algorithm yielded a positive result.

Discussion {#s4}
==========

In this study we constructed and validated billing code algorithms to ascertain PAD status using administrative data. The model-based billing code algorithm had reasonable accuracy for identification of PAD cases and controls (without PAD) from the community, as well as in patients who underwent non-invasive vascular testing. The simpler algorithm based on the presence of one of the commonly used PAD billing codes had reasonable accuracy in identifying PAD in patients referred to the vascular laboratory, but was much less sensitive in detecting patients with PAD in a community-based sample.

The ABI is a commonly used test with relatively high sensitivity and specificity for diagnosing PAD.[@R24] Patients at Mayo Clinic with PAD or suspected of having PAD are typically referred for non-invasive evaluation in the vascular laboratory. Using the training dataset consisting of half of the patients referred to the non-invasive vascular laboratory, we derived a logistic regression model that was reasonably accurate in discriminating PAD status. To avoid overfitting and assure reproducibility of our results the model was validated in an independent validation dataset.

The final model comprised 13 billing codes, including eight ICD-9-CM diagnosis/procedure codes and five CPT-4 diagnostic procedural codes. The scores for diagnosis codes such as 'arteriosclerosis obliterans with gangrene of extremities', 'intermittent claudication', 'ulceration', or 'rest pain' were higher than for procedural codes. Although most revascularization procedures of lower extremity were done for PAD, no such code remained in the final model, probably because the frequency of these procedures in the vascular laboratory population was low.

To evaluate the generalizability of our findings we applied both the model-based billing code algorithm and the simpler algorithm consisting of PAD diagnostic codes to a community-based sample of Olmsted County residents who were not referred to the Mayo vascular laboratory. We used the resources of the REP[@R23] to identify this sample. The REP enables population-based studies of disease risk factors, incidence, and outcomes.[@R23] [@R25] [@R26] Results from studies in Olmsted County have been consistent with national data.[@R26] Age, sex, and ethnic characteristics of Olmsted County residents were similar to those of the state of Minnesota and the upper Midwest. However, Olmsted County residents were less ethnically diverse than the entire US population, more highly educated, and wealthier.[@R26] These insights may guide the generalization of our findings. However, we should emphasize that no single community in the USA is completely representative of the entire USA. Therefore no specific geographic unit can claim any better level of representativeness.[@R26]

Additional work is needed to assess the performance of algorithms for identifying PAD cases and controls at other institutions and to assess the incremental value of additional data sources to enhance the PPV and NPV of EMR-based methods to ascertain PAD. For example, we have previously shown that natural language processing can be used to mine the text in radiology reports to identify cases of PAD.[@R27]

Strengths and limitations {#s4a}
-------------------------

Our study has several strengths. These include the large Mayo Clinic administrative dataset, and the availability of results of non-invasive lower extremity arterial testing performed in the accredited vascular laboratory at Mayo. The initial dataset included all the encounters and line item details of patients with potential PAD over an 11-year period in one medical center. All PAD-related ICD-9-CM diagnosis/procedure codes and CPT-4 procedural codes with updates of new treatment procedures in the time of interest were included, minimizing the possibility of underdiagnosis. As is true for most common diseases, PAD is not always diagnosed using uniform criteria in the present coding systems. This might lead to labeling of patients with different pathological processes as having the same disease. We identified non-atherosclerotic causes of vascular disease and lower extremity treatment procedures unrelated to PAD using relevant billing codes.

Limitations of this study need to be noted. First, diagnosis/procedural codes are assigned for billing and reimbursement. While codes are accurate and complete for these purposes, they may be limited for clinical and research purposes. As for other studies that identify diseases using billing codes and retrospective data over a long time period, the accuracy might have been influenced by bias in coding, modification of disease definition and coding system, the accuracy of recorded data, and potential distortion of information for non-clinical reasons.[@R28] Second, the data for this study were retrieved from databases of a single medical center and the algorithm is likely to perform differently in other medical settings as a result of regional and institutional variations in coding accuracy and thoroughness. The logistic regression model may have to be calibrated at each center.

Conclusion {#s5}
==========

In conclusion, we describe an approach to searching administrative datasets for PAD status using billing codes. The model-based billing code algorithm had reasonable accuracy for identification of PAD status of those in the community, and in patients who were assessed in the non-invasive vascular laboratory. The simpler algorithm based on the presence of any one of the commonly used ICD-9 codes for PAD had reasonable accuracy for identification of PAD in patients evaluated in the vascular laboratory but was significantly less sensitive in a community-based sample. Our approach provides a strategy for rapidly ascertaining PAD status for genetic association and epidemiological studies of PAD.
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